Lantz Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Sell
12,860
-223
-2% -$52K 0.6% 40
2026
Q1
$3.2M Sell
13,083
-1,346
-9% -$314K 0.66% 31
2025
Q4
$2.99M Sell
14,429
-814
-5% -$161K 0.63% 34
2025
Q3
$2.83M Buy
15,243
+3,351
+28% +$574K 0.63% 38
2025
Q2
$1.82M Sell
11,892
-82
-0.7% -$12.6K 0.45% 65
2025
Q1
$1.99M Buy
11,974
+377
+3% +$59K 0.54% 54
2024
Q4
$1.68M Buy
11,597
+273
+2% +$42.3K 0.45% 64
2024
Q3
$1.84M Buy
11,324
+1,223
+12% +$195K 0.5% 62
2024
Q2
$1.48M Sell
10,101
-135
-1% -$20.1K 0.46% 66
2024
Q1
$1.62M Sell
10,236
-102
-1% -$16.2K 0.52% 59
2023
Q4
$1.62M Buy
10,338
+395
+4% +$60.6K 0.59% 50
2023
Q3
$1.55M Buy
9,943
+43
+0.4% +$7.09K 0.62% 46
2023
Q2
$1.64M Sell
9,900
-101
-1% -$16.3K 0.64% 46
2023
Q1
$1.55M Sell
10,001
-306
-3% -$49.4K 0.64% 48
2022
Q4
$1.82M Buy
10,307
+125
+1% +$21.6K 0.83% 32
2022
Q3
$1.66M Sell
10,182
-50
-0.5% -$8.46K 0.87% 28
2022
Q2
$1.82M Buy
10,232
+18
+0.2% +$3.21K 0.82% 26
2022
Q1
$1.81M Buy
10,214
+35
+0.3% +$5.96K 0.74% 33
2021
Q4
$1.74M Sell
10,179
-157
-2% -$25.7K 0.8% 34
2021
Q3
$1.67M Buy
10,336
+285
+3% +$48.6K 0.86% 30
2021
Q2
$1.66M Buy
10,051
+150
+2% +$24.8K 0.85% 31
2021
Q1
$1.63M Buy
9,901
+68
+0.7% +$11K 0.93% 30
2020
Q4
$1.55M Buy
9,833
+411
+4% +$60.7K 0.97% 26
2020
Q3
$1.4M Buy
9,422
+337
+4% +$49.9K 0.94% 32
2020
Q2
$1.28M Buy
9,085
+430
+5% +$62.7K 0.92% 33
2020
Q1
$1.14M Buy
8,655
+1,068
+14% +$152K 0.89% 38
2019
Q4
$1.11M Sell
7,587
-221
-3% -$30K 0.66% 53
2019
Q3
$1.03M Sell
7,808
-230
-3% -$30.3K 0.7% 53
2019
Q2
$1.13M Sell
8,038
-771
-9% -$107K 0.76% 46
2019
Q1
$1.23M Buy
+8,809
New +$1.18M 0.89% 40

Other funds holding JNJ

Lantz Financial's JNJ Position: Q2 2026 in Review

Lantz Financial reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $52K and leaving 12,860 shares worth $3.27M. The position accounts for 0.6% of the portfolio, ranked #40.

Lantz Financial first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lantz Financial held 12,860 shares of Johnson & Johnson worth $3.27M as of Q2 2026.
  • Lantz Financial sold 223 Johnson & Johnson shares in Q2 2026, an estimated $52K.
  • Johnson & Johnson made up 0.6% of Lantz Financial's portfolio in Q2 2026, its #40 holding.
  • Lantz Financial first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.